GURUFOCUS.COM » STOCK LIST » USA » NYSE » Stryker Corp (NYSE:SYK) » Definitions » Change In Payables And Accrued Expense
Switch to:

Stryker (NYSE:SYK) Change In Payables And Accrued Expense

: $310 Mil (TTM As of Jun. 2023)
View and export this data going back to 1988. Start your Free Trial

Stryker's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2023 was $13 Mil. It means Stryker's Accounts Payable & Accrued Expense increased by $13 Mil from Mar. 2023 to Jun. 2023 .

Stryker's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was $380 Mil. It means Stryker's Accounts Payable & Accrued Expense increased by $380 Mil from Dec. 2021 to Dec. 2022 .


Stryker Change In Payables And Accrued Expense Historical Data

The historical data trend for Stryker's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Payables And Accrued Expense
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 249.00 71.00 30.00 546.00 380.00

Stryker Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Change In Payables And Accrued Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.00 209.00 526.00 -438.00 13.00

Stryker Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $310 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stryker Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Stryker's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker (NYSE:SYK) Business Description

Stryker logo
Industry
Traded in Other Exchanges
Address
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Executives
James Andrew Pierce officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio director BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Skeete Tatum Lisa M director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher officer: VP, Chief Legal Officer 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Sherilyn S Mccoy director JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Rajeev Suri director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Mary K Brainerd director 8170 33RD AVENUE SOUTH, BLOOMINGTON MN 55425
Graham A Mclean officer: President, Asia-Pacific 1 CORPORATE AVENUE ROWVILLE, VICTORIA C3 3178
Glenn S Boehnlein officer: Vice President, CFO 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink officer: VP, Global Human Resources 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Yin C Becker officer: VP, Comm. & Public Affairs 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Bijoy Sagar officer: VP, Chief Information Officer 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Michael Damon Hutchinson officer: General Counsel 2825 AIRVIEW BLVD, KALAMAZOO MI 49002